|
Anti-Infective Drugs Advisory Committee Meeting (65th Meeting)
October 15-16, 1998
Holiday Inn, Silver Spring , MD
-
Advisory Committee on Antibiotic Resistance, Dianne Murphy, M.D.
-
Antibiotic Resistance: Regulatory Issues and the Drug Development Process, Albert T. Sheldon, Jr. Ph. D.
-
Bacteremia as an indication - Historical perspective, David Ross, M.D., Ph.D.
-
Bacteremia as an indication - Regulatory perspective, David Ross, M.D., Ph.D.
-
Defining Antibiotic Resistance: Regulatory Perspective, John Alexander, M.D.
-
Development of Drugs for Resistant Bacteria, Janice Soreth, M.D.
-
Problem: Resistance Outpacing Drug Development, Mark J Goldberger MD MPH
-
Regulatory Perspective, Gary Chikami, M.D.
-
Resistance is outpacing drug development, Andrea Meyerhoff MD MSc DTMH
CDER Presentations Page
CDER Home Page | Search | Comment | What's New
|